Trial · NCT06666933
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clinical pregnancy rate for the first embryo transfer | 4-5 weeks after the IVF/ ICSI carried out at the end of the 6 weeks intervention | Clinical pregnancy rate= (number of cycle for 1or more gestational sac is observed via transvaginal ultrasound/ total number of cycle for first embryo transfer)x100% |
| Secondary | Number of retrieved oocytes | After the IVF/ ICSI carried out at the end of the 6 weeks intervention | Includes immature oocytes, mature oocytes and abnormal oocytes from ovum pick-up |
| Secondary | Implantation rate | After the IVF/ ICSI carried out at the end of the 6 weeks intervention | the ration of total number of early gestational sacs to total number of transferred embryos |
| Secondary | Abortion rate | After the IVF/ ICSI carried out at the end of the 6 weeks intervention | the ratio of the number of nonviable pregnancies before 28 weeks of gestation to the number of clinical pregnancies |
| Secondary | Number of good quality embryo | After the IVF/ ICSI carried out at the end of the 6 weeks intervention | Day 3 embryo with 7-9 cells and \<10% fragmentation |
| Secondary | Weight | From enrollment to the end of treatment at 6 weeks | Weight change in kg |
| Secondary | Fat% | From enrollment to the end of treatment at 6 weeks | Inbody machine measurement |
| Secondary | Lipid profile | From enrollment to the end of treatment at 6 weeks | Triglycerol, total cholesterol, HDL, LDL, free fatty acid in mmol/L |
| Secondary | Blood pressure | From enrollment to the end of treatment at 6 weeks | Both systolic and diastolic pressure in mmHg |
| Secondary | Sex hormone | From enrollment to the end of treatment at 6 weeks | DHEAs, testosterone, androstadienone, estradiol, LH, FSH, progesterone, prolactin, SHBG |
| Secondary | OGTT | From enrollment to the end of treatment at 6 weeks | Blood glucose level at 0h, 1h, 2h in mmol/L |
| Secondary | Insulin stimulation | From enrollment to the end of treatment at 6 weeks | Serum insulin level at 0h, 1h, 2h in ng/ml |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06666933/registered